{
  "elements": [
    {
      "objectId": "slide_2038_1_PLACEHOLDER (14)",
      "type": "TEXT_BOX",
      "positionAndSize": {
        "normalized": {
          "x": 0.05173151793525809,
          "y": 0.10000335374744823,
          "width": 0.8833333333333333,
          "height": 0.16666666666666666
        }
      },
      "textContent": "Me Too-Literature Review"
    },
    {
      "objectId": "slide_2038_2_PLACEHOLDER (14)",
      "type": "TEXT_BOX",
      "positionAndSize": {
        "normalized": {
          "x": 0.05416666666666667,
          "y": 0.24444444444444444,
          "width": 0.8819444444444444,
          "height": 0.6222222222222222
        }
      },
      "textContent": "More than 6,000 IRBs connected to universities, federal agencies, medical centers, foundations, or private contract research organizations in the US\nIRBs face heightened workloads due to an exponential growth of clinical trials worldwide, predominantly related to a major increase in pharmaceutical industry sponsorship of health related research. \nIn the United States alone, the drug industry is a 1.3 trillion dollar business or, 13 % of the GNP (Icenogle & Dudek, 2002) \nIRBs are set up to process Industry Sponsored drug and devise studies"
    }
  ],
  "slide_id": "slide_2038"
}